Metraipolis › archive › dc_472b28853fca

Advancing immunotherapy for esophageal cancer: decoding the roles of PD-L1, TME, and tumor-intrinsic biomarkers — Europe PMC PMID:41341591

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41341591
DOI
10.3389/fimmu.2025.1679365
License (as archived)
solo-consultazione
Archived
2026-11-08T11:37:58.804Z
SHA-256 of the archived text
e9f1dc3204c8d07c7fcca9fd39a66ec6bf1908f9f714807f2fb78061013acc33
Stable URL of this page
https://metraipolis.com/documento/dc_472b28853fca

How to cite

Advancing immunotherapy for esophageal cancer: decoding the roles of PD-L1, TME, and tumor-intrinsic biomarkers — Europe PMC PMID:41341591 — Europe PMC (en), https://europepmc.org/article/MED/41341591 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_472b28853fca (Metraipolis archive dc_472b28853fca, sha256 e9f1dc3204c8d07c7fcca9fd39a66ec6bf1908f9f714807f2fb78061013acc33)
BibTeX
@misc{dc472b28853fca,
  title = {Advancing immunotherapy for esophageal cancer: decoding the roles of PD-L1, TME, and tumor-intrinsic biomarkers — Europe PMC PMID:41341591},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41341591},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_472b28853fca; sha256 e9f1dc3204c8d07c7fcca9fd39a66ec6bf1908f9f714807f2fb78061013acc33},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41341591. Agents can read the archived copy with the MCP tool read_document.